What Ophthalmologists Are Thankful For: Dr. Mali’s Top 5 Greatest Innovations Of The 21st Century in Ophthalmology

<p>In this episode, I share my thoughts about the five greatest innovations of the 21st century in the field of ophthalmology and how they have changed patient outcomes for the better.</p> <p><em>Brought to you by Alcon</em></p> <ul> <li>Welcome to another exciting episode of Eye Care insider <strong><em>:50</em></strong></li> <li>My review of the top five innovations in ophthalmology <strong><em>1:02</em></strong></li> <li>Greatest Innovation #1 – anti-VEGF medications <strong><em>2:06</em></strong></li> <li>Greatest Innovation #2 – intraocular lens implantation technology <strong><em>3:26</em></strong></li> <li>Greatest Innovation #3 – electronic medical records <strong><em>4:08</em></strong></li> <li>Greatest Innovation #4 – optical coherence tomography <strong><em>5:48</em></strong></li> <li>Greatest Innovation #5 – telemedicine <strong><em>6:35</em></strong></li> <li>Thanks for listening <strong><em>7:44</em></strong></li> </ul> <p>We’d love to hear from you! Send your comments/questions to Dr. Mali at <a href= "mailto:eyecareinsider@healio.com">eyecareinsider@healio.com</a>. Follow us on Twitter <a href= "https://twitter.com/HRheuminations">@Healio_OSN</a>.</p> <p><strong>Disclosures:</strong> Mali reports he is founder and CEO of Mali Enterprises; retina medical director at Macular Degeneration Association; grant/research support from Alimera Sciences, Allergan/AbbVie, Chengdu Kanghong Biotechnology, Genentech, Notal Vision, Regeneron and Santen; consulting for Alimera Sciences, Allergan/AbbVie, Eyepoint Pharmaceuticals, Genentech, Kala Pharmaceuticals, Macular  Degeneration Association, Notal Vision, Novartis, Regeneron and Sun Pharmaceuticals; speaker bureau for Alimera Sciences, Genentech, Kala Pharmaceuticals, Macular Degeneration Association, Notal Vision, Novartis and Sun Pharmaceuticals; and stock/shareholder with AbbVie and Regeneron.</p>